Skip to main content Skip to section navigation Skip to footer
180 Life Sciences Corp.
  • Home
  • Home
  • About Us
  • Programs
    • Anti-TNF
    • Synthetic CBD Analogs (SCAs)
    • a7nAChR Program
  • Pipeline
  • Leadership
  • Investors
  • Contact Us
  • Contact Us

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Mar 26, 2021 8:30am EDT

180 Life Sciences Corp. (NASDAQ: ATNF) Recognized R&D Pioneers in Anti-Inflammatory Therapeutics

Mar 25, 2021 8:30am EDT

180 Life Sciences Corp. (NASDAQ: ATNF) in Hot Pursuit of New Anti-Inflammatory Blockbusters

Mar 24, 2021 8:30am EDT

180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders

Mar 08, 2021 1:30pm EST

180 Life Sciences Corp. to Present at Inaugural Emerging Growth Virtual Conference, presented by M Vest LLC and Maxim Group LLC

Feb 24, 2021 4:00pm EST

180 Life Sciences Corp. Announces Closing of $11.7 Million Private Placement

Feb 19, 2021 9:00am EST

180 Life Sciences Corp. Announces $11.7 Million Private Placement

Jan 05, 2021 2:50pm EST

180 Life Sciences Corp. to Present at the H.C. Wainwright Bioconnect 2021 Conference

Dec 03, 2020 11:08am EST

180 Life Sciences Corp. to Present at the 13th Annual LD Micro Main Event Conference on Tuesday, December 15th at 1:40 PM EST

Nov 24, 2020 10:00am EST

180 Life Sciences Corp. to Ring Nasdaq Opening Bell on November 27, 2020

Nov 23, 2020 8:30am EST

180 Life Sciences Corp. Continues to Expand Intellectual Property Portfolio With Additional Patent Grants

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© Copyright 2012 - 2025 | 180 Life Sciences Corp. | All Rights Reserved.
  • Visit us on Twitter Twitter
  • Visit us on Linkedin Linkedin